E. Pomeshkin, S. Popov, I. Orlov, M. Shamin, E. Kagan
{"title":"The effectiveness of medical penile rehabilitation after radical prostatectomy","authors":"E. Pomeshkin, S. Popov, I. Orlov, M. Shamin, E. Kagan","doi":"10.17650/2070-9781-2023-24-4-100-110","DOIUrl":null,"url":null,"abstract":"Background. Among the drug methods of penile rehabilitation in patients after nerve-sparing prostatectomy, the use of phosphodiesterase-5 (PDE-5) inhibitors is proposed as the first line of therapy, which have shown high efficiency, ease of use, good tolerability and safety, improving the quality of life of patients.Aim. To evaluate the effectiveness of drug-induced penile rehabilitation after nerve-sparing prostatectomy in the restoration of erectile function (EF) with an analysis of the factors influencing it.Materials and methods. The study included 108 patients with localized prostate cancer who underwent nerve-sparing prostatectomy. All patients were randomized into two groups. In Group 1 patients did not receive drug therapy for the prevention and treatment of erectile dysfunction. In Group 2 patients in the postoperative period received daily PDE-5 inhibitors (tadalafil) at a minimum dosage of 5 mg for 12 months as a drug therapy. Initially and at the annual stage of the study, the state of EF, erectile rigidity, night penile test, and quality of life were assessed. An analysis was also made of the factors affecting the preservation of EF one year after nerve-sparing radical prostatectomy.Results. The best reliable results in terms of maintaining EF at the annual stage of the study were obtained in the group whose patients received postoperative drug therapy with PDE-5 inhibitors. It was possible to identify the most significant factors influencing the state of EF in the postoperative period after radical prostatectomy: the type of operation – bilateral nerve sparing, taking PDE-5 inhibitors, the patient’s age, the presence/absence of diabetes mellitus, the state of EF (International Index of Erectile Function-5 value) before the operation.Conclusion. Daily intake of PDE-5 inhibitors at a low dose of 5 mg is indicated for patients after nerve-sparing prostatectomy as an effective means of penile rehabilitation in order to preserve EF, as it provides better results compared to no drug therapy. Patients who meet criteria such as young age, no diabetes, high preoperative International Index of Erectile Function-5 levels may benefit most from nerve-sparing surgical techniques and early postoperative participation in a penile rehabilitation program for erectile dysfunction.","PeriodicalId":368206,"journal":{"name":"Andrology and Genital Surgery","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrology and Genital Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2070-9781-2023-24-4-100-110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background. Among the drug methods of penile rehabilitation in patients after nerve-sparing prostatectomy, the use of phosphodiesterase-5 (PDE-5) inhibitors is proposed as the first line of therapy, which have shown high efficiency, ease of use, good tolerability and safety, improving the quality of life of patients.Aim. To evaluate the effectiveness of drug-induced penile rehabilitation after nerve-sparing prostatectomy in the restoration of erectile function (EF) with an analysis of the factors influencing it.Materials and methods. The study included 108 patients with localized prostate cancer who underwent nerve-sparing prostatectomy. All patients were randomized into two groups. In Group 1 patients did not receive drug therapy for the prevention and treatment of erectile dysfunction. In Group 2 patients in the postoperative period received daily PDE-5 inhibitors (tadalafil) at a minimum dosage of 5 mg for 12 months as a drug therapy. Initially and at the annual stage of the study, the state of EF, erectile rigidity, night penile test, and quality of life were assessed. An analysis was also made of the factors affecting the preservation of EF one year after nerve-sparing radical prostatectomy.Results. The best reliable results in terms of maintaining EF at the annual stage of the study were obtained in the group whose patients received postoperative drug therapy with PDE-5 inhibitors. It was possible to identify the most significant factors influencing the state of EF in the postoperative period after radical prostatectomy: the type of operation – bilateral nerve sparing, taking PDE-5 inhibitors, the patient’s age, the presence/absence of diabetes mellitus, the state of EF (International Index of Erectile Function-5 value) before the operation.Conclusion. Daily intake of PDE-5 inhibitors at a low dose of 5 mg is indicated for patients after nerve-sparing prostatectomy as an effective means of penile rehabilitation in order to preserve EF, as it provides better results compared to no drug therapy. Patients who meet criteria such as young age, no diabetes, high preoperative International Index of Erectile Function-5 levels may benefit most from nerve-sparing surgical techniques and early postoperative participation in a penile rehabilitation program for erectile dysfunction.
背景。在对神经保留前列腺切除术后患者进行阴茎康复治疗的药物方法中,建议将磷酸二酯酶-5(PDE-5)抑制剂作为一线治疗药物,该药物具有高效、易用、耐受性好、安全性高等特点,可提高患者的生活质量。评估保留神经的前列腺切除术后药物诱导阴茎康复对恢复勃起功能(EF)的有效性,并分析其影响因素。研究纳入了108名接受了保留神经的前列腺切除术的局部前列腺癌患者。所有患者被随机分为两组。第一组患者不接受预防和治疗勃起功能障碍的药物治疗。第 2 组患者在术后接受为期 12 个月的药物治疗,每天服用 PDE-5 抑制剂(他达拉非),最低剂量为 5 毫克。在研究初期和年度阶段,对患者的 EF 状态、勃起硬度、夜间阴茎测试和生活质量进行了评估。此外,还分析了神经保留根治性前列腺切除术一年后影响EF保持的因素。在研究的年度阶段,患者术后接受PDE-5抑制剂药物治疗的一组在维持EF方面取得了最佳的可靠结果。可以确定影响根治性前列腺切除术后EF状况的最重要因素:手术类型--双侧神经疏通术、服用PDE-5抑制剂、患者年龄、有无糖尿病、术前EF状况(勃起功能国际指数-5值)。每天服用5毫克低剂量的PDE-5抑制剂适用于神经保留前列腺切除术后的患者,作为阴茎康复的有效手段,以保持勃起功能指数,因为与不用药治疗相比,服用PDE-5抑制剂的效果更好。符合年轻、无糖尿病、术前国际勃起功能指数(International Index of Erectile Function-5)水平较高等条件的患者可能会从保留神经的手术技术和术后早期参与阴茎康复计划治疗勃起功能障碍中获益最多。